| Market Cap | ₹164.36 CrSmall Cap |
|---|---|
| 1-Year Return | 410%Price Change |
| RSI | 68.05Momentum |
| Deal value | ₹3 Cr |
| Share of market cap | 1.8% |
Key highlights
- Issuance of 3 crore equity warrants with a face value of ₹1 each aggregating to ₹3.00 crore
- Authorised share capital to be increased from ₹15 crore to ₹17.63 crore to facilitate the issue
- Preferential allotment targeted at eleven public/non-promoter investors
- Warrants are convertible into equity shares within a maximum period of 18 months from allotment
- Fund raise represents approximately 1.8 percent of the company's current market capitalisation of ₹164.36 crore
Preferential Allotment and Warrant Conversion Terms
Gujarat Inject (Kerala) Ltd. is proceeding with a preferential issue of 3,00,00,000 equity warrants to 11 identified investors in the public category. Each warrant, with a face value of ₹1, carries the right to apply for and be allotted one equity share of the company upon payment of the full issue price.
The conversion option must be exercised within 18 months from the date of warrant allotment. The final issue price will be determined based on SEBI ICDR Regulations. This move follows a period of significant operational momentum, including a ₹6.25 crore order from Deon Energy and a ₹4.86 crore order from Zentaraa Infra Projects, both announced in October 2026.
Strategic Increase in Authorised Capital
- Current authorised share capital stands at ₹15,00,00,000
- Proposed increase to ₹17,63,48,000 representing an addition of ₹2.63 crore
- Adjustment is designed to accommodate the new issuance while maintaining regulatory headroom
- Existing paid-up share capital is currently recorded at ₹14,63,48,000
- Changes are subject to the approval of shareholders in an Extra-Ordinary General Meeting
Diversified Participation Among Key Public Investors
The preferential issue is distributed among eleven investors, with JV Investment, a partnership firm, taking the largest portion of 1,90,00,000 warrants. Other significant participants include Ramchandra Dallaram Choudhary with 25,00,000 warrants and Ankit Jain and Yogendrakumar Gupta HUF with 20,00,000 warrants each. This capital raise lands on a balance sheet that has seen rapid growth; the company reported a June 2026 quarter revenue of ₹12.45 crore, representing a 414.4 percent year-on-year increase.
Net profit for the same period surged by 1602.9 percent to ₹1.25 crore, supported by an operating margin of 13.6 percent.
| Date | Announcement | Amount |
|---|---|---|
| 26 Oct 2026 | Preferential issue of equity shares and warrants (rescheduled board meeting)Source: scanx.trade | – |
| 22 Oct 2026 | Preferential issue of equity shares and warrants (board meeting intimation)Source: BSE filing | – |
What to watch next
- Shareholder approval at the upcoming Extra-Ordinary General Meeting
- Board meeting on November 5, 2026, to approve financial results for the September quarter
- Execution of current solar PV module order book valued at over ₹21.6 crore as of July 2026
| Share price | ₹11.22 |
|---|---|
| Market capitalisation | ₹164.36 Cr |
| Revenue (annual) | ₹36.32 Cr |
| Net profit (annual) | ₹1.81 Cr |
| Revenue (latest quarter) | ₹12.45 Cr-59.43% vs previous quarter |
| Net profit (latest quarter) | ₹1.25 Cr-23.45% vs previous quarter |
| P/E (TTM) | 54.93×Sector 48.73× |
| FII holding | 0%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Gujarat Inject (Kerala) Ltd. announcing the outcome of the Board Meeting held on October 29, 2026. Market figures from a third-party data provider.
